Pearl Street Venture Funds (PSVF)
Pearl Street Venture Funds (PSVF) is dedicated to supporting innovative entrepreneurs by building valuable, entrepreneurial-driven companies and generating impressive returns for limited partners. Founded by experienced entrepreneurs and veteran venture capitalists, PSVF primarily invests in life sciences companies with transformative innovations.
Pearl Street Venture Funds (PSVF)
Portfolio
Founded on the scientific discoveries of Dr. Mark R. Kelley, focusing on APE1/Ref-1 redox protein signaling.
#Biotechnology
Developed microbial detection technology for environmental monitoring. Acquired by Yamatake, Inc.
#Pharmaceutical, Biotechnology, Healthcare
Focused on therapies for CNS disorders and other conditions. Acquired by Eli Lilly and Company, Inc.
#Biotechnology
Full-service parenteral contract manufacturer. Majority purchase by Arlington Capital Partners.
#Pharmaceutical Manufacturing
#Technology
Advanced a proprietary approach for immunomodulatory therapy based on synthetic ligands for the TLR2 receptor.
#Biotechnology
Developed small molecule Hsp90 inhibitors. Acquired by Pfizer, Inc.
#Biotechnology
Key People
Managing Director
Managing Director
Managing Director
Managing Director